RT Journal Article
T1 SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).
A1 de la Haba-Rodriguez, Juan
A1 Lloret, Ferran Ferragut
A1 Salgado, Maria Angeles Vaz
A1 Arce, Marin Ore
A1 Gutierrez, Ana Cardeña
A1 Jimenez, Jesus Garcia-Donas
A1 Zambrano, Carmen Beato
A1 Alonso, Rosa Maria Rodriguez
A1 Lopez, Rafael Lopez
A1 Salas, Nuria Rodriguez
K1 Biomarkers
K1 Molecular platforms
K1 Next-generation sequencing
K1 Precision medicine
K1 Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
AB The improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the determination of molecular alterations in the diagnosis and treatment of cancer. The use of multidetermination platforms is spreading in most Spanish hospitals. The objective of these clinical practice guides is to review their usefulness, and establish usage guidelines that guide their incorporation into clinical practice.
PB Springer
YR 2022
FD 2022-02-22
LK http://hdl.handle.net/10668/21141
UL http://hdl.handle.net/10668/21141
LA en
NO de la Haba-Rodriguez J, Lloret FF, Salgado MAV, Arce MO, Gutiérrez AC, Jiménez JG, et al. SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021). Clin Transl Oncol. 2022 Apr;24(4):693-702
DS RISalud
RD Apr 6, 2025